Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing virtual diabetes self-management education in two health systems (VIDA): a mixed-methods pilot study.

Frontiers in clinical diabetes and healthcare·2026
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

Plasma Cytokine and Chemokine Profile in Hospitalized Toxic Epidermal Necrolysis Patients.

Clinical and experimental dermatology·2026
Same author

Persistent microglial activation following neonatal CMV infection mediates neurodegeneration.

Science advances·2026
Same author

Universal Newborn Screening for Congenital Cytomegalovirus Using Dried Blood Spot Specimens.

JAMA network open·2026
Same author

The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Related Experiment Video

Updated: Mar 14, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.9K

CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.

Corinne J Smith1, Michael Quinn1, Christopher M Snyder1

  • 1Department of Microbiology and Immunology, Thomas Jefferson University , Philadelphia, PA , USA.

Frontiers in Immunology
|October 4, 2016
PubMed
Summary

Adoptive T cell therapy can prevent human cytomegalovirus (HCMV) reactivation in transplant patients. However, current methods may not fully restore diverse CD8+ T cell subsets needed for long-term immunity.

Keywords:
CMV-specific CD8 T cellsT cell localizationadoptive T cell therapyeffector T cellsmemory T cellstissue-resident memory cells

More Related Videos

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.9K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.4K

Related Experiment Videos

Last Updated: Mar 14, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.9K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.9K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.4K

Area of Science:

  • Immunology
  • Virology
  • Cellular Biology

Background:

  • Human cytomegalovirus (HCMV) is a common cause of serious infection in immunocompromised individuals, particularly transplant recipients.
  • Adoptive transfer of HCMV-specific T cells is a promising immunotherapy to restore anti-HCMV immunity.
  • The heterogeneity of CD8+ T cell subsets and their roles in HCMV immunity are not fully understood in the context of current therapies.

Approach:

  • This review summarizes the distinct functions and localizations of HCMV-specific CD8+ T cell subsets.
  • It examines how current adoptive immunotherapy protocols may impact the reconstitution of these diverse T cell populations.
  • The focus is on terminally differentiated effector cells, self-renewing memory cells, and tissue-resident memory T cells.

Key Points:

  • Terminally differentiated effector CD8+ T cells provide immediate but short-lived responses.
  • Self-renewing memory CD8+ T cells are crucial for sustained immunity against HCMV.
  • Tissue-resident memory T cells in mucosal sites are vital for controlling reactivation but do not recirculate.

Conclusions:

  • Current adoptive immunotherapy may not adequately reconstitute the full spectrum of HCMV-specific CD8+ T cell immunity.
  • Future strategies should aim to balance the generation of different T cell subsets for durable and protective responses.
  • Optimizing T cell subset reconstitution is essential for preventing HCMV disease in vulnerable populations.